Memory CD8 T cells are crucial for protective immunity against viral infections. Their development involves three phases: initial activation and expansion, a contraction or death phase, and the formation of memory T cells. During the initial phase, naive T cells expand and gain effector functions. A small fraction survives the death phase and differentiates into memory T cells. Recent studies show that brief antigen exposure can initiate differentiation, leading to memory T cells without further antigenic stimulation. In acute infections, memory CD8 T cells are generated through a linear process, with effector cells differentiating into memory cells. These memory cells have distinct phenotypes, such as central memory (T_CM) and effector memory (T_EM) T cells, which differ in their homing properties and functions. T_CM cells are more effective in protective immunity due to their higher proliferative capacity and ability to respond to antigen. During chronic infections, memory CD8 T cells may experience functional exhaustion, characterized by a loss of effector functions. This exhaustion can progress through stages, leading to partial or full functional impairment. Chronic infections can also lead to T-cell deletion, further reducing the effectiveness of immune responses. The role of CD4 T-cell help is critical in maintaining CD8 T-cell function, especially during chronic infections. Understanding these processes is essential for vaccine design, as inducing memory T cells with high proliferative potential is key to effective immunity. Therapeutic strategies may involve reducing viral load or restoring T-cell function to combat chronic infections. Challenges include ensuring optimal CD4 T-cell help and timing booster vaccinations to maximize memory T-cell differentiation. Future research aims to improve therapeutic approaches by addressing the functional defects in chronically infected individuals.Memory CD8 T cells are crucial for protective immunity against viral infections. Their development involves three phases: initial activation and expansion, a contraction or death phase, and the formation of memory T cells. During the initial phase, naive T cells expand and gain effector functions. A small fraction survives the death phase and differentiates into memory T cells. Recent studies show that brief antigen exposure can initiate differentiation, leading to memory T cells without further antigenic stimulation. In acute infections, memory CD8 T cells are generated through a linear process, with effector cells differentiating into memory cells. These memory cells have distinct phenotypes, such as central memory (T_CM) and effector memory (T_EM) T cells, which differ in their homing properties and functions. T_CM cells are more effective in protective immunity due to their higher proliferative capacity and ability to respond to antigen. During chronic infections, memory CD8 T cells may experience functional exhaustion, characterized by a loss of effector functions. This exhaustion can progress through stages, leading to partial or full functional impairment. Chronic infections can also lead to T-cell deletion, further reducing the effectiveness of immune responses. The role of CD4 T-cell help is critical in maintaining CD8 T-cell function, especially during chronic infections. Understanding these processes is essential for vaccine design, as inducing memory T cells with high proliferative potential is key to effective immunity. Therapeutic strategies may involve reducing viral load or restoring T-cell function to combat chronic infections. Challenges include ensuring optimal CD4 T-cell help and timing booster vaccinations to maximize memory T-cell differentiation. Future research aims to improve therapeutic approaches by addressing the functional defects in chronically infected individuals.